Kinetics of sickle hemoglobin polymerization. Thermodynamics of the Polymerization of Protein (Academic Press, 1975).įerrone, F.A., Hofrichter, J. Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Kar, K., Jayaraman, M., Sahoo, B., Kodali, R. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Direct observation of the interconversion of normal and toxic forms of α-synuclein. An analytical solution to the kinetics of breakable filament assembly. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055–1058 (1993). Mechanism of prion propagation: amyloid growth occurs by monomer addition. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Biology of amyloid: structure, function, and regulation. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Amyloid fibril protein nomenclature: 2012 recommendations from the nomenclature committee of the International Society of Amyloidosis. The amyloid state and its association with protein misfolding diseases. Protein misfolding, functional amyloid, and human disease. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Protein aggregation diseases: pathogenicity and therapeutic perspectives. These results reveal that molecular chaperones can help maintain protein homeostasis by selectively suppressing critical microscopic steps within the complex reaction pathways responsible for the toxic effects of protein misfolding and aggregation.Īguzzi, A. We verify that this mechanism occurs in living mouse brain tissue by cytotoxicity and electrophysiology experiments. We demonstrate in vitro that Brichos achieves this inhibition by binding to the surfaces of fibrils, thereby redirecting the aggregation reaction to a pathway that involves minimal formation of toxic oligomeric intermediates. Here we show that a molecular chaperone, a human Brichos domain, can specifically inhibit this catalytic cycle and limit human Aβ42 toxicity. Recent studies have revealed that once Aβ42 fibrils are generated, their surfaces effectively catalyze the formation of neurotoxic oligomers. Alzheimer's disease is an increasingly prevalent neurodegenerative disorder whose pathogenesis has been associated with aggregation of the amyloid-β peptide (Aβ42).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |